Companies: 10,795·Total market cap: $144.5T
Molecular Pharmacology (USA), Ltd.

Molecular Pharmacology (USA), Ltd.

MLPHOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$111554
P/E Ratio
52W High$0.0097
52W Low$0.0001

Molecular Pharmacology (USA), Ltd. (MLPH) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

MLPH · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.
No earnings history available.
No analyst estimates available for MLPH.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: MLPH ends December

Molecular Pharmacology (USA), Ltd. (MLPH) reports earnings quarterly as a OTC-listed Biotechnology company. The next MLPH earnings date is expected around September 1, 2026.

Each quarter, investors track MLPH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MLPH revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MLPH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Frequently asked questions

MLPH earnings · 3 questions

Molecular Pharmacology (USA), Ltd.'s next earnings report is expected around September 1, 2026. MLPH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MLPH historically reports after market close (AMC).

MLPH earnings datewhen is MLPH earningsMLPH next earnings datewhen does MLPH report earningsMLPH earnings calendar

Source: FMP · Molecular Pharmacology (USA), Ltd. SEC filings · US GAAP · Molecular Pharmacology (USA), Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026